SB2321 amends the Illinois Pharmacy Practice Act to create a new concept called a “first-choice pharmacy.” Under the bill, a patient’s designated first-choice pharmacy would be allowed to forward a prescription order to another pharmacy if it cannot fill or provide the medication itself. The measure is aimed at preserving access to prescriptions when the patient’s preferred pharmacy is out of stock, unable to dispense, or otherwise unable to complete the order.
The bill is narrow in scope and does not appear to change prescribing authority or insurance coverage rules directly. Instead, it adds a new statutory provision governing pharmacy-to-pharmacy transfer of prescription orders in limited circumstances. By authorizing forwarding to another pharmacy, the bill would affect pharmacies, pharmacists, and patients who rely on a preferred local pharmacy for medication access.
Impact
If enacted, SB2321 would add Section 45 to the Pharmacy Practice Act and formally recognize a “first-choice pharmacy” process in Illinois law. The practical effect would be to permit a pharmacy that cannot fill a prescription to forward the order to another pharmacy that can, potentially reducing delays and improving continuity of access to medications. It would primarily affect pharmacy operations and prescription handling procedures rather than broader health care regulation.
Sentiment
There is little recorded public debate in the available materials, and no committee transcripts or votes are provided. Based on the bill text and caption, the measure appears to be a straightforward access-to-medication proposal with an administrative rather than controversial policy change. The available record suggests neutral to favorable treatment, but there is not enough voting or hearing history to identify a broader consensus or opposition.
Contention
No specific points of contention are documented in the available committee or voting history. Potential areas of concern, if raised later, could include pharmacy workflow, patient consent, prescription transfer safeguards, and whether the forwarding process could affect patient choice or competition among pharmacies. However, the provided record does not show any named opponents, supporters, or disputed provisions.
Pharmaceuticals; prohibiting the Board of Pharmacy from disciplining pharmacists who recommend off-label use of a drug; allowing over-the-counter sale of Ivermectin and Hydroxychloroquine.
A bill for an act relating to pharmacy benefits managers, pharmacies, prescription drugs, and pharmacy services administrative organizations, and including applicability provisions. (Formerly SSB 1074.) Effective date: 07/01/2025. Applicability date: 07/01/2025.